Purdue Pharma filed for bankruptcy with a more than US$10 billion plan to settle claims that it fuelled the US opioid epidemic by illegally pushing sales of its addictive OxyContin painkiller.The Chapter 11 filing on Sunday in White…
Source: NZ Herald Business News